Success Metrics

Clinical Success Rate
64.3%

Based on 9 completed trials

Completion Rate
64%(9/14)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
5(36%)

Phase Distribution

Ph phase_3
14
100%

Phase Distribution

0

Early Stage

0

Mid Stage

14

Late Stage

Phase Distribution14 total trials
Phase 3Large-scale testing
14(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

64.3%

9 of 14 finished

Non-Completion Rate

35.7%

5 ended early

Currently Active

0

trials recruiting

Total Trials

14

all time

Status Distribution
Completed(9)
Terminated(5)

Detailed Status

Completed9
Terminated5

Development Timeline

Analytics

Development Status

Total Trials
14
Active
0
Success Rate
64.3%
Most Advanced
Phase 3

Trials by Phase

Phase 314 (100.0%)

Trials by Status

completed964%
terminated536%

Recent Activity

0 active trials
Showing 5 of 14
completedphase_3

Carotid B-Mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrpib/Atorvastatin to Atorvastatin Alone.

NCT00136981
terminatedphase_3

Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin.

NCT00134238
completedphase_3

A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol

NCT00138762
terminatedphase_3

Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder.

NCT00145431
terminatedphase_3

A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol (A5091031).

NCT00267280
View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT00136981Phase 3

Carotid B-Mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrpib/Atorvastatin to Atorvastatin Alone.

Completed
NCT00134238Phase 3

Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin.

Terminated
NCT00138762Phase 3

A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol

Completed
NCT00145431Phase 3

Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder.

Terminated
NCT00267280Phase 3

A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol (A5091031).

Terminated
NCT00134264Phase 3

A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart Disease

Terminated
NCT00267267Phase 3

A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder.

Terminated
NCT00134173Phase 3

A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease

Completed
NCT00267254Phase 3

A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol.

Completed
NCT00134498Phase 3

A Study Comparing The Efficacy & Safety Of Torcetrapib/Atorvastatin And Atorvastatin In Subjects With High Triglycerides

Completed
NCT00137462Phase 3

Lipitor Trial To Study The Effect Of Torcetrpib/Atorvastatin To Atorvastatin Alone.

Completed
NCT00134511Phase 3

Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder

Completed
NCT00139061Phase 3

Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate

Completed
NCT00134485Phase 3

Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia

Completed

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14